nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—ABCB1—hematologic cancer	0.116	1	CbGaD
Loratadine—CYP2C9—Bexarotene—hematologic cancer	0.0203	0.0333	CbGbCtD
Loratadine—ABCB1—Lenalidomide—hematologic cancer	0.0197	0.0323	CbGbCtD
Loratadine—CYP2C8—Bortezomib—hematologic cancer	0.0179	0.0293	CbGbCtD
Loratadine—CYP2D6—Lomustine—hematologic cancer	0.0173	0.0283	CbGbCtD
Loratadine—CYP2C9—Idarubicin—hematologic cancer	0.0169	0.0276	CbGbCtD
Loratadine—CYP2D6—Idarubicin—hematologic cancer	0.0154	0.0252	CbGbCtD
Loratadine—CYP2C19—Bortezomib—hematologic cancer	0.015	0.0245	CbGbCtD
Loratadine—CYP2C8—Ifosfamide—hematologic cancer	0.0137	0.0224	CbGbCtD
Loratadine—CYP2D6—Hydroxyurea—hematologic cancer	0.0131	0.0215	CbGbCtD
Loratadine—CYP2C19—Thalidomide—hematologic cancer	0.0131	0.0214	CbGbCtD
Loratadine—CYP2C9—Bortezomib—hematologic cancer	0.0125	0.0204	CbGbCtD
Loratadine—CYP2C19—Teniposide—hematologic cancer	0.0125	0.0204	CbGbCtD
Loratadine—CYP2C8—Nilotinib—hematologic cancer	0.0119	0.0195	CbGbCtD
Loratadine—CYP3A4—Bexarotene—hematologic cancer	0.0118	0.0194	CbGbCtD
Loratadine—ABCB1—Daunorubicin—hematologic cancer	0.0116	0.0189	CbGbCtD
Loratadine—CYP2C19—Ifosfamide—hematologic cancer	0.0115	0.0188	CbGbCtD
Loratadine—CYP2D6—Bortezomib—hematologic cancer	0.0114	0.0187	CbGbCtD
Loratadine—ABCB1—Alitretinoin—hematologic cancer	0.0113	0.0186	CbGbCtD
Loratadine—CYP3A4—Lomustine—hematologic cancer	0.011	0.018	CbGbCtD
Loratadine—CYP3A4—Busulfan—hematologic cancer	0.011	0.018	CbGbCtD
Loratadine—CYP2C19—Imatinib—hematologic cancer	0.011	0.018	CbGbCtD
Loratadine—CYP2C9—Thalidomide—hematologic cancer	0.0109	0.0178	CbGbCtD
Loratadine—CYP2C9—Teniposide—hematologic cancer	0.0104	0.017	CbGbCtD
Loratadine—CYP3A4—Thiotepa—hematologic cancer	0.0098	0.016	CbGbCtD
Loratadine—CYP2C9—Ifosfamide—hematologic cancer	0.00957	0.0157	CbGbCtD
Loratadine—CYP2C9—Imatinib—hematologic cancer	0.00914	0.015	CbGbCtD
Loratadine—ABCB1—Imatinib—hematologic cancer	0.00887	0.0145	CbGbCtD
Loratadine—CYP2D6—Imatinib—hematologic cancer	0.00836	0.0137	CbGbCtD
Loratadine—CYP2C9—Nilotinib—hematologic cancer	0.0083	0.0136	CbGbCtD
Loratadine—ABCB1—Nilotinib—hematologic cancer	0.00806	0.0132	CbGbCtD
Loratadine—ABCB1—Vinorelbine—hematologic cancer	0.00799	0.0131	CbGbCtD
Loratadine—CYP3A4—Methoxsalen—hematologic cancer	0.00762	0.0125	CbGbCtD
Loratadine—CYP2D6—Nilotinib—hematologic cancer	0.00759	0.0124	CbGbCtD
Loratadine—CYP2D6—Vinorelbine—hematologic cancer	0.00753	0.0123	CbGbCtD
Loratadine—CYP3A4—Bortezomib—hematologic cancer	0.00725	0.0119	CbGbCtD
Loratadine—CYP2C19—Prednisone—hematologic cancer	0.00724	0.0119	CbGbCtD
Loratadine—ABCB1—Dasatinib—hematologic cancer	0.00712	0.0117	CbGbCtD
Loratadine—ABCB1—Mitoxantrone—hematologic cancer	0.00704	0.0115	CbGbCtD
Loratadine—CYP3A4—Daunorubicin—hematologic cancer	0.00694	0.0114	CbGbCtD
Loratadine—CYP2C8—Etoposide—hematologic cancer	0.00655	0.0107	CbGbCtD
Loratadine—ABCB1—Betamethasone—hematologic cancer	0.00627	0.0103	CbGbCtD
Loratadine—ABCB1—Gemcitabine—hematologic cancer	0.00621	0.0102	CbGbCtD
Loratadine—ABCB1—Prednisolone—hematologic cancer	0.00619	0.0101	CbGbCtD
Loratadine—CYP3A4—Cytarabine—hematologic cancer	0.00612	0.01	CbGbCtD
Loratadine—CYP3A4—Teniposide—hematologic cancer	0.00603	0.00986	CbGbCtD
Loratadine—ABCB1—Prednisone—hematologic cancer	0.00584	0.00956	CbGbCtD
Loratadine—CYP3A4—Ifosfamide—hematologic cancer	0.00556	0.0091	CbGbCtD
Loratadine—ABCB1—Irinotecan—hematologic cancer	0.00554	0.00906	CbGbCtD
Loratadine—CYP2C8—Dexamethasone—hematologic cancer	0.00539	0.00882	CbGbCtD
Loratadine—CYP3A4—Imatinib—hematologic cancer	0.00531	0.0087	CbGbCtD
Loratadine—CYP3A4—Ruxolitinib—hematologic cancer	0.005	0.00819	CbGbCtD
Loratadine—ABCB1—Vinblastine—hematologic cancer	0.00492	0.00806	CbGbCtD
Loratadine—ABCB1—Vincristine—hematologic cancer	0.00484	0.00792	CbGbCtD
Loratadine—CYP3A4—Nilotinib—hematologic cancer	0.00483	0.0079	CbGbCtD
Loratadine—CYP3A4—Vinorelbine—hematologic cancer	0.00479	0.00784	CbGbCtD
Loratadine—CYP2C9—Cisplatin—hematologic cancer	0.00465	0.00761	CbGbCtD
Loratadine—CYP2D6—Vinblastine—hematologic cancer	0.00464	0.00759	CbGbCtD
Loratadine—CYP2C19—Dexamethasone—hematologic cancer	0.00452	0.0074	CbGbCtD
Loratadine—ABCB1—Cisplatin—hematologic cancer	0.00452	0.00739	CbGbCtD
Loratadine—ABCB1—Etoposide—hematologic cancer	0.00444	0.00726	CbGbCtD
Loratadine—CYP3A4—Triamcinolone—hematologic cancer	0.00438	0.00717	CbGbCtD
Loratadine—CYP3A4—Dasatinib—hematologic cancer	0.00427	0.00698	CbGbCtD
Loratadine—CYP3A4—Mitoxantrone—hematologic cancer	0.00422	0.0069	CbGbCtD
Loratadine—CYP2C9—Dexamethasone—hematologic cancer	0.00376	0.00615	CbGbCtD
Loratadine—CYP3A4—Betamethasone—hematologic cancer	0.00376	0.00615	CbGbCtD
Loratadine—CYP3A4—Prednisolone—hematologic cancer	0.00371	0.00607	CbGbCtD
Loratadine—ABCB1—Dexamethasone—hematologic cancer	0.00365	0.00597	CbGbCtD
Loratadine—CYP3A4—Prednisone—hematologic cancer	0.0035	0.00573	CbGbCtD
Loratadine—CYP2D6—Dexamethasone—hematologic cancer	0.00344	0.00562	CbGbCtD
Loratadine—CYP3A4—Irinotecan—hematologic cancer	0.00332	0.00543	CbGbCtD
Loratadine—ABCB1—Doxorubicin—hematologic cancer	0.00303	0.00495	CbGbCtD
Loratadine—CYP3A4—Vinblastine—hematologic cancer	0.00295	0.00483	CbGbCtD
Loratadine—ABCB1—Methotrexate—hematologic cancer	0.00293	0.0048	CbGbCtD
Loratadine—CYP3A4—Vincristine—hematologic cancer	0.0029	0.00475	CbGbCtD
Loratadine—CYP2D6—Doxorubicin—hematologic cancer	0.00285	0.00467	CbGbCtD
Loratadine—CYP3A4—Etoposide—hematologic cancer	0.00266	0.00435	CbGbCtD
Loratadine—CYP3A4—Dexamethasone—hematologic cancer	0.00219	0.00358	CbGbCtD
Loratadine—CYP3A4—Doxorubicin—hematologic cancer	0.00181	0.00297	CbGbCtD
Loratadine—Ketotifen—PDE4B—hematologic cancer	0.00119	0.761	CrCbGaD
Loratadine—Desloratadine—ABCB1—hematologic cancer	0.000375	0.239	CrCbGaD
Loratadine—CYP2C19—hematopoietic system—hematologic cancer	0.000175	0.0709	CbGeAlD
Loratadine—KCNH2—hematopoietic system—hematologic cancer	0.000167	0.0676	CbGeAlD
Loratadine—CYP2C8—hematopoietic system—hematologic cancer	0.000153	0.0619	CbGeAlD
Loratadine—CYP2C9—hematopoietic system—hematologic cancer	0.000136	0.055	CbGeAlD
Loratadine—HRH1—hematopoietic system—hematologic cancer	0.000134	0.0542	CbGeAlD
Loratadine—CYP2C19—blood—hematologic cancer	0.000116	0.047	CbGeAlD
Loratadine—KCNH2—blood—hematologic cancer	0.000111	0.0448	CbGeAlD
Loratadine—KCNH2—bone marrow—hematologic cancer	0.000107	0.0434	CbGeAlD
Loratadine—CYP3A4—hematopoietic system—hematologic cancer	0.000103	0.0419	CbGeAlD
Loratadine—CYP2D6—hematopoietic system—hematologic cancer	0.000102	0.0413	CbGeAlD
Loratadine—CYP2C8—blood—hematologic cancer	0.000101	0.041	CbGeAlD
Loratadine—KCNH2—testis—hematologic cancer	9.15e-05	0.0371	CbGeAlD
Loratadine—CYP2C9—blood—hematologic cancer	8.99e-05	0.0364	CbGeAlD
Loratadine—CYP2C8—testis—hematologic cancer	8.37e-05	0.0339	CbGeAlD
Loratadine—HRH1—lung—hematologic cancer	7.77e-05	0.0315	CbGeAlD
Loratadine—HRH1—testis—hematologic cancer	7.34e-05	0.0297	CbGeAlD
Loratadine—ABCB1—hematopoietic system—hematologic cancer	7.33e-05	0.0297	CbGeAlD
Loratadine—CYP3A4—blood—hematologic cancer	6.86e-05	0.0278	CbGeAlD
Loratadine—CYP2D6—blood—hematologic cancer	6.75e-05	0.0273	CbGeAlD
Loratadine—KCNH2—lymph node—hematologic cancer	6.63e-05	0.0269	CbGeAlD
Loratadine—Fatigue—Triamcinolone—hematologic cancer	5.68e-05	0.000264	CcSEcCtD
Loratadine—Rash—Vincristine—hematologic cancer	5.65e-05	0.000263	CcSEcCtD
Loratadine—Dermatitis—Vincristine—hematologic cancer	5.65e-05	0.000262	CcSEcCtD
Loratadine—Pain—Triamcinolone—hematologic cancer	5.63e-05	0.000262	CcSEcCtD
Loratadine—Headache—Vincristine—hematologic cancer	5.62e-05	0.000261	CcSEcCtD
Loratadine—Loss of consciousness—Prednisone—hematologic cancer	5.61e-05	0.000261	CcSEcCtD
Loratadine—Hepatobiliary disease—Doxorubicin—hematologic cancer	5.59e-05	0.00026	CcSEcCtD
Loratadine—Hypotension—Betamethasone—hematologic cancer	5.59e-05	0.00026	CcSEcCtD
Loratadine—Hypotension—Dexamethasone—hematologic cancer	5.59e-05	0.00026	CcSEcCtD
Loratadine—CYP2D6—testis—hematologic cancer	5.58e-05	0.0226	CbGeAlD
Loratadine—Nausea—Carmustine—hematologic cancer	5.58e-05	0.000259	CcSEcCtD
Loratadine—Epistaxis—Doxorubicin—hematologic cancer	5.57e-05	0.000259	CcSEcCtD
Loratadine—ABCB1—gonad—hematologic cancer	5.57e-05	0.0226	CbGeAlD
Loratadine—Vomiting—Mitoxantrone—hematologic cancer	5.55e-05	0.000258	CcSEcCtD
Loratadine—Vomiting—Irinotecan—hematologic cancer	5.55e-05	0.000258	CcSEcCtD
Loratadine—Immune system disorder—Methotrexate—hematologic cancer	5.53e-05	0.000257	CcSEcCtD
Loratadine—Nausea—Alitretinoin—hematologic cancer	5.53e-05	0.000257	CcSEcCtD
Loratadine—Hypertension—Prednisone—hematologic cancer	5.51e-05	0.000256	CcSEcCtD
Loratadine—Rash—Mitoxantrone—hematologic cancer	5.51e-05	0.000256	CcSEcCtD
Loratadine—Rash—Irinotecan—hematologic cancer	5.51e-05	0.000256	CcSEcCtD
Loratadine—Dermatitis—Irinotecan—hematologic cancer	5.5e-05	0.000256	CcSEcCtD
Loratadine—Dermatitis—Mitoxantrone—hematologic cancer	5.5e-05	0.000256	CcSEcCtD
Loratadine—Headache—Irinotecan—hematologic cancer	5.47e-05	0.000254	CcSEcCtD
Loratadine—Headache—Mitoxantrone—hematologic cancer	5.47e-05	0.000254	CcSEcCtD
Loratadine—Nausea—Ifosfamide—hematologic cancer	5.46e-05	0.000254	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5.45e-05	0.000253	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.45e-05	0.000253	CcSEcCtD
Loratadine—Myalgia—Prednisone—hematologic cancer	5.43e-05	0.000252	CcSEcCtD
Loratadine—Feeling abnormal—Triamcinolone—hematologic cancer	5.43e-05	0.000252	CcSEcCtD
Loratadine—Diarrhoea—Cisplatin—hematologic cancer	5.43e-05	0.000252	CcSEcCtD
Loratadine—Alopecia—Methotrexate—hematologic cancer	5.41e-05	0.000251	CcSEcCtD
Loratadine—Vomiting—Gemcitabine—hematologic cancer	5.41e-05	0.000251	CcSEcCtD
Loratadine—Insomnia—Dexamethasone—hematologic cancer	5.41e-05	0.000251	CcSEcCtD
Loratadine—Insomnia—Betamethasone—hematologic cancer	5.41e-05	0.000251	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	5.39e-05	0.000251	CcSEcCtD
Loratadine—Paraesthesia—Betamethasone—hematologic cancer	5.37e-05	0.000249	CcSEcCtD
Loratadine—Paraesthesia—Dexamethasone—hematologic cancer	5.37e-05	0.000249	CcSEcCtD
Loratadine—Discomfort—Prednisone—hematologic cancer	5.37e-05	0.000249	CcSEcCtD
Loratadine—Rash—Gemcitabine—hematologic cancer	5.36e-05	0.000249	CcSEcCtD
Loratadine—Dermatitis—Gemcitabine—hematologic cancer	5.36e-05	0.000249	CcSEcCtD
Loratadine—Tinnitus—Epirubicin—hematologic cancer	5.34e-05	0.000248	CcSEcCtD
Loratadine—Headache—Gemcitabine—hematologic cancer	5.33e-05	0.000248	CcSEcCtD
Loratadine—Nausea—Vincristine—hematologic cancer	5.33e-05	0.000248	CcSEcCtD
Loratadine—HRH1—lymph node—hematologic cancer	5.32e-05	0.0215	CbGeAlD
Loratadine—Pharyngitis—Doxorubicin—hematologic cancer	5.26e-05	0.000245	CcSEcCtD
Loratadine—Dyspepsia—Betamethasone—hematologic cancer	5.26e-05	0.000245	CcSEcCtD
Loratadine—Dyspepsia—Dexamethasone—hematologic cancer	5.26e-05	0.000245	CcSEcCtD
Loratadine—Dysgeusia—Methotrexate—hematologic cancer	5.22e-05	0.000243	CcSEcCtD
Loratadine—Asthenia—Etoposide—hematologic cancer	5.21e-05	0.000242	CcSEcCtD
Loratadine—Body temperature increased—Triamcinolone—hematologic cancer	5.21e-05	0.000242	CcSEcCtD
Loratadine—Anaphylactic shock—Prednisone—hematologic cancer	5.21e-05	0.000242	CcSEcCtD
Loratadine—Nausea—Irinotecan—hematologic cancer	5.19e-05	0.000241	CcSEcCtD
Loratadine—Nausea—Mitoxantrone—hematologic cancer	5.19e-05	0.000241	CcSEcCtD
Loratadine—Immune system disorder—Epirubicin—hematologic cancer	5.18e-05	0.000241	CcSEcCtD
Loratadine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.16e-05	0.00024	CcSEcCtD
Loratadine—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.16e-05	0.00024	CcSEcCtD
Loratadine—Fatigue—Dexamethasone—hematologic cancer	5.15e-05	0.000239	CcSEcCtD
Loratadine—Fatigue—Betamethasone—hematologic cancer	5.15e-05	0.000239	CcSEcCtD
Loratadine—Shock—Prednisone—hematologic cancer	5.12e-05	0.000238	CcSEcCtD
Loratadine—Arrhythmia—Epirubicin—hematologic cancer	5.12e-05	0.000238	CcSEcCtD
Loratadine—Pain—Dexamethasone—hematologic cancer	5.11e-05	0.000238	CcSEcCtD
Loratadine—Pain—Betamethasone—hematologic cancer	5.11e-05	0.000238	CcSEcCtD
Loratadine—Nervous system disorder—Prednisone—hematologic cancer	5.11e-05	0.000237	CcSEcCtD
Loratadine—Tachycardia—Prednisone—hematologic cancer	5.08e-05	0.000236	CcSEcCtD
Loratadine—Alopecia—Epirubicin—hematologic cancer	5.06e-05	0.000235	CcSEcCtD
Loratadine—Skin disorder—Prednisone—hematologic cancer	5.06e-05	0.000235	CcSEcCtD
Loratadine—Nausea—Gemcitabine—hematologic cancer	5.05e-05	0.000235	CcSEcCtD
Loratadine—Vomiting—Cisplatin—hematologic cancer	5.04e-05	0.000234	CcSEcCtD
Loratadine—Rash—Cisplatin—hematologic cancer	5e-05	0.000232	CcSEcCtD
Loratadine—Dermatitis—Cisplatin—hematologic cancer	4.99e-05	0.000232	CcSEcCtD
Loratadine—Diarrhoea—Etoposide—hematologic cancer	4.97e-05	0.000231	CcSEcCtD
Loratadine—Ill-defined disorder—Methotrexate—hematologic cancer	4.95e-05	0.00023	CcSEcCtD
Loratadine—Tinnitus—Doxorubicin—hematologic cancer	4.94e-05	0.00023	CcSEcCtD
Loratadine—Feeling abnormal—Betamethasone—hematologic cancer	4.93e-05	0.000229	CcSEcCtD
Loratadine—Feeling abnormal—Dexamethasone—hematologic cancer	4.93e-05	0.000229	CcSEcCtD
Loratadine—Tension—Epirubicin—hematologic cancer	4.9e-05	0.000227	CcSEcCtD
Loratadine—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.89e-05	0.000227	CcSEcCtD
Loratadine—Gastrointestinal pain—Betamethasone—hematologic cancer	4.89e-05	0.000227	CcSEcCtD
Loratadine—Dysgeusia—Epirubicin—hematologic cancer	4.89e-05	0.000227	CcSEcCtD
Loratadine—ABCB1—blood—hematologic cancer	4.85e-05	0.0197	CbGeAlD
Loratadine—Nervousness—Epirubicin—hematologic cancer	4.85e-05	0.000225	CcSEcCtD
Loratadine—Malaise—Methotrexate—hematologic cancer	4.81e-05	0.000223	CcSEcCtD
Loratadine—Dizziness—Etoposide—hematologic cancer	4.8e-05	0.000223	CcSEcCtD
Loratadine—Immune system disorder—Doxorubicin—hematologic cancer	4.79e-05	0.000223	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.74e-05	0.00022	CcSEcCtD
Loratadine—Dizziness—Prednisolone—hematologic cancer	4.74e-05	0.00022	CcSEcCtD
Loratadine—Arrhythmia—Doxorubicin—hematologic cancer	4.74e-05	0.00022	CcSEcCtD
Loratadine—Asthenia—Triamcinolone—hematologic cancer	4.73e-05	0.00022	CcSEcCtD
Loratadine—Abdominal pain—Betamethasone—hematologic cancer	4.73e-05	0.00022	CcSEcCtD
Loratadine—Abdominal pain—Dexamethasone—hematologic cancer	4.73e-05	0.00022	CcSEcCtD
Loratadine—Body temperature increased—Dexamethasone—hematologic cancer	4.73e-05	0.00022	CcSEcCtD
Loratadine—Body temperature increased—Betamethasone—hematologic cancer	4.73e-05	0.00022	CcSEcCtD
Loratadine—Nausea—Cisplatin—hematologic cancer	4.71e-05	0.000219	CcSEcCtD
Loratadine—Insomnia—Prednisone—hematologic cancer	4.71e-05	0.000219	CcSEcCtD
Loratadine—ABCB1—bone marrow—hematologic cancer	4.7e-05	0.019	CbGeAlD
Loratadine—Alopecia—Doxorubicin—hematologic cancer	4.69e-05	0.000218	CcSEcCtD
Loratadine—Paraesthesia—Prednisone—hematologic cancer	4.67e-05	0.000217	CcSEcCtD
Loratadine—Cough—Methotrexate—hematologic cancer	4.65e-05	0.000216	CcSEcCtD
Loratadine—Ill-defined disorder—Epirubicin—hematologic cancer	4.63e-05	0.000215	CcSEcCtD
Loratadine—Vomiting—Etoposide—hematologic cancer	4.62e-05	0.000215	CcSEcCtD
Loratadine—Agitation—Epirubicin—hematologic cancer	4.58e-05	0.000213	CcSEcCtD
Loratadine—Dyspepsia—Prednisone—hematologic cancer	4.58e-05	0.000213	CcSEcCtD
Loratadine—Rash—Etoposide—hematologic cancer	4.58e-05	0.000213	CcSEcCtD
Loratadine—Dermatitis—Etoposide—hematologic cancer	4.58e-05	0.000213	CcSEcCtD
Loratadine—Headache—Etoposide—hematologic cancer	4.55e-05	0.000211	CcSEcCtD
Loratadine—Myalgia—Methotrexate—hematologic cancer	4.54e-05	0.000211	CcSEcCtD
Loratadine—Chest pain—Methotrexate—hematologic cancer	4.54e-05	0.000211	CcSEcCtD
Loratadine—Tension—Doxorubicin—hematologic cancer	4.53e-05	0.00021	CcSEcCtD
Loratadine—Dysgeusia—Doxorubicin—hematologic cancer	4.52e-05	0.00021	CcSEcCtD
Loratadine—Rash—Prednisolone—hematologic cancer	4.52e-05	0.00021	CcSEcCtD
Loratadine—Dermatitis—Prednisolone—hematologic cancer	4.51e-05	0.00021	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.51e-05	0.000209	CcSEcCtD
Loratadine—Malaise—Epirubicin—hematologic cancer	4.5e-05	0.000209	CcSEcCtD
Loratadine—Fatigue—Prednisone—hematologic cancer	4.49e-05	0.000209	CcSEcCtD
Loratadine—Headache—Prednisolone—hematologic cancer	4.49e-05	0.000209	CcSEcCtD
Loratadine—Discomfort—Methotrexate—hematologic cancer	4.48e-05	0.000208	CcSEcCtD
Loratadine—Nervousness—Doxorubicin—hematologic cancer	4.48e-05	0.000208	CcSEcCtD
Loratadine—Syncope—Epirubicin—hematologic cancer	4.47e-05	0.000208	CcSEcCtD
Loratadine—Constipation—Prednisone—hematologic cancer	4.45e-05	0.000207	CcSEcCtD
Loratadine—Palpitations—Epirubicin—hematologic cancer	4.41e-05	0.000205	CcSEcCtD
Loratadine—Loss of consciousness—Epirubicin—hematologic cancer	4.39e-05	0.000204	CcSEcCtD
Loratadine—Dizziness—Triamcinolone—hematologic cancer	4.36e-05	0.000202	CcSEcCtD
Loratadine—Cough—Epirubicin—hematologic cancer	4.35e-05	0.000202	CcSEcCtD
Loratadine—Anaphylactic shock—Methotrexate—hematologic cancer	4.35e-05	0.000202	CcSEcCtD
Loratadine—Nausea—Etoposide—hematologic cancer	4.31e-05	0.0002	CcSEcCtD
Loratadine—Hypertension—Epirubicin—hematologic cancer	4.31e-05	0.0002	CcSEcCtD
Loratadine—Feeling abnormal—Prednisone—hematologic cancer	4.29e-05	0.000199	CcSEcCtD
Loratadine—Asthenia—Dexamethasone—hematologic cancer	4.29e-05	0.000199	CcSEcCtD
Loratadine—Asthenia—Betamethasone—hematologic cancer	4.29e-05	0.000199	CcSEcCtD
Loratadine—Ill-defined disorder—Doxorubicin—hematologic cancer	4.28e-05	0.000199	CcSEcCtD
Loratadine—Nervous system disorder—Methotrexate—hematologic cancer	4.27e-05	0.000198	CcSEcCtD
Loratadine—Gastrointestinal pain—Prednisone—hematologic cancer	4.26e-05	0.000198	CcSEcCtD
Loratadine—Nausea—Prednisolone—hematologic cancer	4.26e-05	0.000198	CcSEcCtD
Loratadine—ABCB1—lung—hematologic cancer	4.25e-05	0.0172	CbGeAlD
Loratadine—Myalgia—Epirubicin—hematologic cancer	4.25e-05	0.000197	CcSEcCtD
Loratadine—Chest pain—Epirubicin—hematologic cancer	4.25e-05	0.000197	CcSEcCtD
Loratadine—Agitation—Doxorubicin—hematologic cancer	4.24e-05	0.000197	CcSEcCtD
Loratadine—Skin disorder—Methotrexate—hematologic cancer	4.23e-05	0.000196	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.22e-05	0.000196	CcSEcCtD
Loratadine—Discomfort—Epirubicin—hematologic cancer	4.2e-05	0.000195	CcSEcCtD
Loratadine—Vomiting—Triamcinolone—hematologic cancer	4.19e-05	0.000195	CcSEcCtD
Loratadine—Malaise—Doxorubicin—hematologic cancer	4.16e-05	0.000193	CcSEcCtD
Loratadine—Rash—Triamcinolone—hematologic cancer	4.15e-05	0.000193	CcSEcCtD
Loratadine—Dry mouth—Epirubicin—hematologic cancer	4.15e-05	0.000193	CcSEcCtD
Loratadine—Dermatitis—Triamcinolone—hematologic cancer	4.15e-05	0.000193	CcSEcCtD
Loratadine—Syncope—Doxorubicin—hematologic cancer	4.14e-05	0.000192	CcSEcCtD
Loratadine—Headache—Triamcinolone—hematologic cancer	4.13e-05	0.000192	CcSEcCtD
Loratadine—Abdominal pain—Prednisone—hematologic cancer	4.12e-05	0.000191	CcSEcCtD
Loratadine—Body temperature increased—Prednisone—hematologic cancer	4.12e-05	0.000191	CcSEcCtD
Loratadine—Diarrhoea—Dexamethasone—hematologic cancer	4.09e-05	0.00019	CcSEcCtD
Loratadine—Diarrhoea—Betamethasone—hematologic cancer	4.09e-05	0.00019	CcSEcCtD
Loratadine—Palpitations—Doxorubicin—hematologic cancer	4.08e-05	0.00019	CcSEcCtD
Loratadine—Anaphylactic shock—Epirubicin—hematologic cancer	4.07e-05	0.000189	CcSEcCtD
Loratadine—Hypotension—Methotrexate—hematologic cancer	4.07e-05	0.000189	CcSEcCtD
Loratadine—Loss of consciousness—Doxorubicin—hematologic cancer	4.06e-05	0.000189	CcSEcCtD
Loratadine—Cough—Doxorubicin—hematologic cancer	4.03e-05	0.000187	CcSEcCtD
Loratadine—ABCB1—testis—hematologic cancer	4.01e-05	0.0163	CbGeAlD
Loratadine—Shock—Epirubicin—hematologic cancer	4.01e-05	0.000186	CcSEcCtD
Loratadine—Nervous system disorder—Epirubicin—hematologic cancer	3.99e-05	0.000186	CcSEcCtD
Loratadine—Hypertension—Doxorubicin—hematologic cancer	3.99e-05	0.000185	CcSEcCtD
Loratadine—Tachycardia—Epirubicin—hematologic cancer	3.97e-05	0.000185	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.96e-05	0.000184	CcSEcCtD
Loratadine—Skin disorder—Epirubicin—hematologic cancer	3.96e-05	0.000184	CcSEcCtD
Loratadine—Dizziness—Betamethasone—hematologic cancer	3.95e-05	0.000184	CcSEcCtD
Loratadine—Dizziness—Dexamethasone—hematologic cancer	3.95e-05	0.000184	CcSEcCtD
Loratadine—Insomnia—Methotrexate—hematologic cancer	3.94e-05	0.000183	CcSEcCtD
Loratadine—Chest pain—Doxorubicin—hematologic cancer	3.93e-05	0.000183	CcSEcCtD
Loratadine—Myalgia—Doxorubicin—hematologic cancer	3.93e-05	0.000183	CcSEcCtD
Loratadine—Nausea—Triamcinolone—hematologic cancer	3.91e-05	0.000182	CcSEcCtD
Loratadine—Paraesthesia—Methotrexate—hematologic cancer	3.91e-05	0.000182	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.9e-05	0.000181	CcSEcCtD
Loratadine—Discomfort—Doxorubicin—hematologic cancer	3.88e-05	0.00018	CcSEcCtD
Loratadine—Somnolence—Methotrexate—hematologic cancer	3.87e-05	0.00018	CcSEcCtD
Loratadine—Dry mouth—Doxorubicin—hematologic cancer	3.84e-05	0.000179	CcSEcCtD
Loratadine—Dyspepsia—Methotrexate—hematologic cancer	3.83e-05	0.000178	CcSEcCtD
Loratadine—Hypotension—Epirubicin—hematologic cancer	3.8e-05	0.000177	CcSEcCtD
Loratadine—Vomiting—Dexamethasone—hematologic cancer	3.8e-05	0.000177	CcSEcCtD
Loratadine—Vomiting—Betamethasone—hematologic cancer	3.8e-05	0.000177	CcSEcCtD
Loratadine—Rash—Betamethasone—hematologic cancer	3.77e-05	0.000175	CcSEcCtD
Loratadine—Rash—Dexamethasone—hematologic cancer	3.77e-05	0.000175	CcSEcCtD
Loratadine—Anaphylactic shock—Doxorubicin—hematologic cancer	3.77e-05	0.000175	CcSEcCtD
Loratadine—Dermatitis—Dexamethasone—hematologic cancer	3.77e-05	0.000175	CcSEcCtD
Loratadine—Dermatitis—Betamethasone—hematologic cancer	3.77e-05	0.000175	CcSEcCtD
Loratadine—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.76e-05	0.000175	CcSEcCtD
Loratadine—Fatigue—Methotrexate—hematologic cancer	3.75e-05	0.000174	CcSEcCtD
Loratadine—Headache—Betamethasone—hematologic cancer	3.75e-05	0.000174	CcSEcCtD
Loratadine—Headache—Dexamethasone—hematologic cancer	3.75e-05	0.000174	CcSEcCtD
Loratadine—Asthenia—Prednisone—hematologic cancer	3.74e-05	0.000174	CcSEcCtD
Loratadine—Pain—Methotrexate—hematologic cancer	3.72e-05	0.000173	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.71e-05	0.000172	CcSEcCtD
Loratadine—Shock—Doxorubicin—hematologic cancer	3.71e-05	0.000172	CcSEcCtD
Loratadine—Nervous system disorder—Doxorubicin—hematologic cancer	3.69e-05	0.000172	CcSEcCtD
Loratadine—Insomnia—Epirubicin—hematologic cancer	3.68e-05	0.000171	CcSEcCtD
Loratadine—Tachycardia—Doxorubicin—hematologic cancer	3.68e-05	0.000171	CcSEcCtD
Loratadine—Skin disorder—Doxorubicin—hematologic cancer	3.66e-05	0.00017	CcSEcCtD
Loratadine—Paraesthesia—Epirubicin—hematologic cancer	3.66e-05	0.00017	CcSEcCtD
Loratadine—Somnolence—Epirubicin—hematologic cancer	3.62e-05	0.000168	CcSEcCtD
Loratadine—Feeling abnormal—Methotrexate—hematologic cancer	3.59e-05	0.000167	CcSEcCtD
Loratadine—Dyspepsia—Epirubicin—hematologic cancer	3.58e-05	0.000167	CcSEcCtD
Loratadine—Diarrhoea—Prednisone—hematologic cancer	3.56e-05	0.000166	CcSEcCtD
Loratadine—Gastrointestinal pain—Methotrexate—hematologic cancer	3.56e-05	0.000165	CcSEcCtD
Loratadine—Nausea—Betamethasone—hematologic cancer	3.55e-05	0.000165	CcSEcCtD
Loratadine—Nausea—Dexamethasone—hematologic cancer	3.55e-05	0.000165	CcSEcCtD
Loratadine—Hypotension—Doxorubicin—hematologic cancer	3.52e-05	0.000164	CcSEcCtD
Loratadine—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.52e-05	0.000163	CcSEcCtD
Loratadine—Fatigue—Epirubicin—hematologic cancer	3.51e-05	0.000163	CcSEcCtD
Loratadine—Pain—Epirubicin—hematologic cancer	3.48e-05	0.000162	CcSEcCtD
Loratadine—Constipation—Epirubicin—hematologic cancer	3.48e-05	0.000162	CcSEcCtD
Loratadine—Dizziness—Prednisone—hematologic cancer	3.44e-05	0.00016	CcSEcCtD
Loratadine—Abdominal pain—Methotrexate—hematologic cancer	3.44e-05	0.00016	CcSEcCtD
Loratadine—Body temperature increased—Methotrexate—hematologic cancer	3.44e-05	0.00016	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.43e-05	0.00016	CcSEcCtD
Loratadine—Insomnia—Doxorubicin—hematologic cancer	3.41e-05	0.000158	CcSEcCtD
Loratadine—Paraesthesia—Doxorubicin—hematologic cancer	3.38e-05	0.000157	CcSEcCtD
Loratadine—Feeling abnormal—Epirubicin—hematologic cancer	3.36e-05	0.000156	CcSEcCtD
Loratadine—Somnolence—Doxorubicin—hematologic cancer	3.35e-05	0.000156	CcSEcCtD
Loratadine—Gastrointestinal pain—Epirubicin—hematologic cancer	3.33e-05	0.000155	CcSEcCtD
Loratadine—Dyspepsia—Doxorubicin—hematologic cancer	3.32e-05	0.000154	CcSEcCtD
Loratadine—Vomiting—Prednisone—hematologic cancer	3.31e-05	0.000154	CcSEcCtD
Loratadine—Rash—Prednisone—hematologic cancer	3.28e-05	0.000153	CcSEcCtD
Loratadine—Dermatitis—Prednisone—hematologic cancer	3.28e-05	0.000152	CcSEcCtD
Loratadine—Headache—Prednisone—hematologic cancer	3.26e-05	0.000152	CcSEcCtD
Loratadine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.25e-05	0.000151	CcSEcCtD
Loratadine—Fatigue—Doxorubicin—hematologic cancer	3.25e-05	0.000151	CcSEcCtD
Loratadine—Pain—Doxorubicin—hematologic cancer	3.22e-05	0.00015	CcSEcCtD
Loratadine—Constipation—Doxorubicin—hematologic cancer	3.22e-05	0.00015	CcSEcCtD
Loratadine—Abdominal pain—Epirubicin—hematologic cancer	3.22e-05	0.00015	CcSEcCtD
Loratadine—Body temperature increased—Epirubicin—hematologic cancer	3.22e-05	0.00015	CcSEcCtD
Loratadine—Asthenia—Methotrexate—hematologic cancer	3.12e-05	0.000145	CcSEcCtD
Loratadine—Feeling abnormal—Doxorubicin—hematologic cancer	3.1e-05	0.000144	CcSEcCtD
Loratadine—Nausea—Prednisone—hematologic cancer	3.09e-05	0.000144	CcSEcCtD
Loratadine—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.08e-05	0.000143	CcSEcCtD
Loratadine—Abdominal pain—Doxorubicin—hematologic cancer	2.98e-05	0.000138	CcSEcCtD
Loratadine—Body temperature increased—Doxorubicin—hematologic cancer	2.98e-05	0.000138	CcSEcCtD
Loratadine—Diarrhoea—Methotrexate—hematologic cancer	2.98e-05	0.000138	CcSEcCtD
Loratadine—Asthenia—Epirubicin—hematologic cancer	2.92e-05	0.000136	CcSEcCtD
Loratadine—ABCB1—lymph node—hematologic cancer	2.91e-05	0.0118	CbGeAlD
Loratadine—Dizziness—Methotrexate—hematologic cancer	2.88e-05	0.000134	CcSEcCtD
Loratadine—Diarrhoea—Epirubicin—hematologic cancer	2.79e-05	0.000129	CcSEcCtD
Loratadine—Vomiting—Methotrexate—hematologic cancer	2.77e-05	0.000129	CcSEcCtD
Loratadine—Rash—Methotrexate—hematologic cancer	2.74e-05	0.000127	CcSEcCtD
Loratadine—Dermatitis—Methotrexate—hematologic cancer	2.74e-05	0.000127	CcSEcCtD
Loratadine—Headache—Methotrexate—hematologic cancer	2.73e-05	0.000127	CcSEcCtD
Loratadine—Asthenia—Doxorubicin—hematologic cancer	2.7e-05	0.000126	CcSEcCtD
Loratadine—Dizziness—Epirubicin—hematologic cancer	2.69e-05	0.000125	CcSEcCtD
Loratadine—Vomiting—Epirubicin—hematologic cancer	2.59e-05	0.00012	CcSEcCtD
Loratadine—Nausea—Methotrexate—hematologic cancer	2.58e-05	0.00012	CcSEcCtD
Loratadine—Diarrhoea—Doxorubicin—hematologic cancer	2.58e-05	0.00012	CcSEcCtD
Loratadine—Rash—Epirubicin—hematologic cancer	2.57e-05	0.000119	CcSEcCtD
Loratadine—Dermatitis—Epirubicin—hematologic cancer	2.56e-05	0.000119	CcSEcCtD
Loratadine—Headache—Epirubicin—hematologic cancer	2.55e-05	0.000119	CcSEcCtD
Loratadine—Dizziness—Doxorubicin—hematologic cancer	2.49e-05	0.000116	CcSEcCtD
Loratadine—Nausea—Epirubicin—hematologic cancer	2.42e-05	0.000112	CcSEcCtD
Loratadine—Vomiting—Doxorubicin—hematologic cancer	2.4e-05	0.000111	CcSEcCtD
Loratadine—Rash—Doxorubicin—hematologic cancer	2.38e-05	0.00011	CcSEcCtD
Loratadine—Dermatitis—Doxorubicin—hematologic cancer	2.37e-05	0.00011	CcSEcCtD
Loratadine—Headache—Doxorubicin—hematologic cancer	2.36e-05	0.00011	CcSEcCtD
Loratadine—Nausea—Doxorubicin—hematologic cancer	2.24e-05	0.000104	CcSEcCtD
Loratadine—ABCB1—Metabolism—SDC1—hematologic cancer	6.19e-06	0.000116	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ENO2—hematologic cancer	6.15e-06	0.000115	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3R1—hematologic cancer	6.15e-06	0.000115	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.15e-06	0.000115	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ENO2—hematologic cancer	6.1e-06	0.000114	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.06e-06	0.000113	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NQO1—hematologic cancer	6.04e-06	0.000113	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CD44—hematologic cancer	6.04e-06	0.000113	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.98e-06	0.000112	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—JAK2—hematologic cancer	5.97e-06	0.000111	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTT1—hematologic cancer	5.97e-06	0.000111	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—MAP2K1—hematologic cancer	5.95e-06	0.000111	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.93e-06	0.000111	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—GRB2—hematologic cancer	5.92e-06	0.00011	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—IDH2—hematologic cancer	5.92e-06	0.00011	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HMMR—hematologic cancer	5.92e-06	0.00011	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.92e-06	0.00011	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.91e-06	0.00011	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CD—hematologic cancer	5.91e-06	0.00011	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PDGFA—hematologic cancer	5.91e-06	0.00011	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—SDC1—hematologic cancer	5.83e-06	0.000109	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.82e-06	0.000109	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KITLG—hematologic cancer	5.82e-06	0.000109	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—SDC1—hematologic cancer	5.78e-06	0.000108	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.72e-06	0.000107	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYCS—hematologic cancer	5.72e-06	0.000107	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—STAT5A—hematologic cancer	5.69e-06	0.000106	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	5.68e-06	0.000106	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CB—hematologic cancer	5.67e-06	0.000106	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN2B—hematologic cancer	5.64e-06	0.000105	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3R1—hematologic cancer	5.58e-06	0.000104	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.56e-06	0.000104	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.55e-06	0.000104	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.52e-06	0.000103	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CD86—hematologic cancer	5.45e-06	0.000102	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.45e-06	0.000102	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—JAK2—hematologic cancer	5.42e-06	0.000101	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CA9—hematologic cancer	5.41e-06	0.000101	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ACP5—hematologic cancer	5.41e-06	0.000101	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CD44—hematologic cancer	5.39e-06	0.000101	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NQO1—hematologic cancer	5.39e-06	0.000101	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HES1—hematologic cancer	5.38e-06	0.0001	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NCOR1—hematologic cancer	5.35e-06	9.98e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.34e-06	9.97e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CSF2—hematologic cancer	5.29e-06	9.87e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGF1—hematologic cancer	5.29e-06	9.87e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.28e-06	9.85e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NQO1—hematologic cancer	5.26e-06	9.82e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CD44—hematologic cancer	5.26e-06	9.82e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.22e-06	9.73e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FOXO1—hematologic cancer	5.21e-06	9.73e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—IL2—hematologic cancer	5.21e-06	9.72e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PDGFRB—hematologic cancer	5.2e-06	9.71e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CB—hematologic cancer	5.15e-06	9.62e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PDGFRA—hematologic cancer	5.12e-06	9.56e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.11e-06	9.54e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JAK1—hematologic cancer	5.11e-06	9.53e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PRKCG—hematologic cancer	5.11e-06	9.53e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYCS—hematologic cancer	5.1e-06	9.52e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—IDH1—hematologic cancer	5.09e-06	9.5e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.07e-06	9.46e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTP1—hematologic cancer	5.04e-06	9.4e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.03e-06	9.39e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—TXN—hematologic cancer	5.03e-06	9.39e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.03e-06	9.39e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYCS—hematologic cancer	4.98e-06	9.29e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CD44—hematologic cancer	4.96e-06	9.25e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NQO1—hematologic cancer	4.96e-06	9.25e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.95e-06	9.23e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.92e-06	9.19e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CD44—hematologic cancer	4.92e-06	9.17e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NQO1—hematologic cancer	4.92e-06	9.17e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.87e-06	9.1e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.81e-06	8.98e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.77e-06	8.9e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL2RA—hematologic cancer	4.77e-06	8.9e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL2—hematologic cancer	4.73e-06	8.83e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.73e-06	8.83e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TERT—hematologic cancer	4.71e-06	8.8e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYCS—hematologic cancer	4.69e-06	8.76e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.66e-06	8.7e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYCS—hematologic cancer	4.65e-06	8.68e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—NCOR1—hematologic cancer	4.63e-06	8.64e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTM1—hematologic cancer	4.63e-06	8.64e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.62e-06	8.63e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.6e-06	8.59e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.6e-06	8.59e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PDGFB—hematologic cancer	4.6e-06	8.59e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.56e-06	8.51e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TSC2—hematologic cancer	4.5e-06	8.39e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.5e-06	8.39e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.48e-06	8.37e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTP1—hematologic cancer	4.39e-06	8.19e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.35e-06	8.12e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NUP98—hematologic cancer	4.34e-06	8.11e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGFR3—hematologic cancer	4.33e-06	8.07e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK14—hematologic cancer	4.28e-06	7.99e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ABCB1—hematologic cancer	4.26e-06	7.94e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.22e-06	7.87e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.22e-06	7.87e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ESR1—hematologic cancer	4.2e-06	7.84e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NUP214—hematologic cancer	4.19e-06	7.81e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.16e-06	7.76e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FN1—hematologic cancer	4.15e-06	7.75e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.14e-06	7.72e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.13e-06	7.71e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.13e-06	7.71e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTR—hematologic cancer	4.1e-06	7.65e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.1e-06	7.65e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	4.1e-06	7.65e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—BAD—hematologic cancer	4.1e-06	7.65e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.1e-06	7.65e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—MTHFR—hematologic cancer	4.09e-06	7.64e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	4.06e-06	7.58e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NCOR1—hematologic cancer	4.03e-06	7.53e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTM1—hematologic cancer	4.03e-06	7.53e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ENO2—hematologic cancer	4.02e-06	7.51e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CD80—hematologic cancer	3.98e-06	7.43e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KIT—hematologic cancer	3.97e-06	7.41e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	3.97e-06	7.41e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—NRAS—hematologic cancer	3.97e-06	7.41e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.97e-06	7.4e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.92e-06	7.31e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTPN11—hematologic cancer	3.9e-06	7.28e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.9e-06	7.28e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.88e-06	7.24e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—SDC1—hematologic cancer	3.81e-06	7.12e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	3.8e-06	7.1e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.8e-06	7.09e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.8e-06	7.09e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CREB1—hematologic cancer	3.78e-06	7.06e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.77e-06	7.03e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.77e-06	7.03e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—BRAF—hematologic cancer	3.73e-06	6.97e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCL2—hematologic cancer	3.7e-06	6.9e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6R—hematologic cancer	3.69e-06	6.88e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CREBBP—hematologic cancer	3.68e-06	6.87e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.65e-06	6.82e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.61e-06	6.73e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—MTHFR—hematologic cancer	3.56e-06	6.65e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	3.51e-06	6.56e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	3.49e-06	6.52e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.46e-06	6.45e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.44e-06	6.42e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—KRAS—hematologic cancer	3.42e-06	6.38e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.36e-06	6.27e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—FGF2—hematologic cancer	3.34e-06	6.24e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.33e-06	6.21e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	3.3e-06	6.15e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CD44—hematologic cancer	3.24e-06	6.05e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NQO1—hematologic cancer	3.24e-06	6.05e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.22e-06	6.01e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JAK2—hematologic cancer	3.2e-06	5.98e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CREBBP—hematologic cancer	3.19e-06	5.95e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	3.14e-06	5.86e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MDM2—hematologic cancer	3.13e-06	5.84e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.07e-06	5.73e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.07e-06	5.73e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.05e-06	5.69e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	3.04e-06	5.68e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MTOR—hematologic cancer	3.04e-06	5.68e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	3.02e-06	5.64e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.99e-06	5.59e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ALB—hematologic cancer	2.98e-06	5.57e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.93e-06	5.48e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	2.91e-06	5.42e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	2.86e-06	5.33e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.85e-06	5.33e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.84e-06	5.31e-05	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	2.83e-06	5.27e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.82e-06	5.27e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CASP3—hematologic cancer	2.8e-06	5.22e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.8e-06	5.22e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL2—hematologic cancer	2.8e-06	5.22e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL6—hematologic cancer	2.78e-06	5.19e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CREBBP—hematologic cancer	2.78e-06	5.18e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCND1—hematologic cancer	2.72e-06	5.09e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JUN—hematologic cancer	2.72e-06	5.07e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.7e-06	5.05e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.7e-06	5.03e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALB—hematologic cancer	2.66e-06	4.97e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	2.64e-06	4.92e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.63e-06	4.92e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.63e-06	4.91e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PTEN—hematologic cancer	2.63e-06	4.91e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.62e-06	4.88e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALB—hematologic cancer	2.6e-06	4.85e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.59e-06	4.84e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	2.57e-06	4.8e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	2.57e-06	4.79e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.56e-06	4.78e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.55e-06	4.75e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—EP300—hematologic cancer	2.51e-06	4.68e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.49e-06	4.64e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.48e-06	4.64e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.48e-06	4.64e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.48e-06	4.63e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.46e-06	4.59e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALB—hematologic cancer	2.45e-06	4.57e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SRC—hematologic cancer	2.44e-06	4.55e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALB—hematologic cancer	2.43e-06	4.53e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	2.38e-06	4.43e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—STAT3—hematologic cancer	2.35e-06	4.39e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.35e-06	4.39e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—NRAS—hematologic cancer	2.35e-06	4.38e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.34e-06	4.37e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.32e-06	4.33e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.29e-06	4.28e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PTEN—hematologic cancer	2.28e-06	4.25e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	2.25e-06	4.19e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.2e-06	4.1e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MYC—hematologic cancer	2.19e-06	4.08e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	2.18e-06	4.07e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—EP300—hematologic cancer	2.17e-06	4.05e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.16e-06	4.04e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.14e-06	4e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PTEN—hematologic cancer	2.03e-06	3.79e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KRAS—hematologic cancer	2.02e-06	3.77e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PTEN—hematologic cancer	1.98e-06	3.7e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—EP300—hematologic cancer	1.94e-06	3.62e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—EP300—hematologic cancer	1.89e-06	3.53e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.87e-06	3.49e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.86e-06	3.46e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.85e-06	3.46e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.85e-06	3.44e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TP53—hematologic cancer	1.79e-06	3.35e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—EP300—hematologic cancer	1.78e-06	3.33e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—EP300—hematologic cancer	1.77e-06	3.3e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.72e-06	3.2e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.71e-06	3.19e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6—hematologic cancer	1.64e-06	3.07e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.62e-06	3.03e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.61e-06	3e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALB—hematologic cancer	1.6e-06	2.99e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.53e-06	2.86e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.52e-06	2.83e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.43e-06	2.67e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.41e-06	2.64e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.4e-06	2.61e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.32e-06	2.46e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKT1—hematologic cancer	1.31e-06	2.45e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.31e-06	2.44e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.22e-06	2.28e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKT1—hematologic cancer	1.17e-06	2.19e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—EP300—hematologic cancer	1.17e-06	2.17e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKT1—hematologic cancer	1.14e-06	2.13e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.08e-06	2.01e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKT1—hematologic cancer	1.07e-06	1.99e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.62e-07	1.61e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKT1—hematologic cancer	7.04e-07	1.31e-05	CbGpPWpGaD
